GILEAD GS-US-223-1017

Investigator: Mahendra Jain, MD

Study Coordinator: Bela Jain

Status: Enrolling

ClinicalTrials.gov Number: NCT04026165

Phone: 281.485.3434

Protocol Number: Pro00022451

Description

To evaluate whether selonsertib (SEL) can slow the decline in kidney function, reduce the risk of kidney failure, or reduce the risk of death due to kidney disease in subjects with diabetic kidney disease (DKD)
More to Explore
Live Chat Available